{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T10:55:43Z","timestamp":1762340143080},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.jbspin.2006.11.013","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T12:54:55Z","timestamp":1180097695000},"page":"316-318","source":"Crossref","is-referenced-by-count":15,"title":["Biologics in the treatment of primary inflammatory myositis"],"prefix":"10.1016","volume":"74","author":[{"given":"Daniel","family":"Wendling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2006.11.013_bib1","first-page":"1556","article-title":"Polymyosite, dermatomyosite, myosite \u00e0 inclusions, aspects nosologiques","volume":"32","author":"Eymard","year":"2003","journal-title":"Presse Med"},{"key":"10.1016\/j.jbspin.2006.11.013_bib2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s100670070027","article-title":"Elevation of serum soluble tumour necrosis factor receptors in patients with polymyositis and dermatomyositis","volume":"19","author":"Shimizu","year":"2000","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2006.11.013_bib3","first-page":"1668","article-title":"Traitement des myopathies inflammatoires","volume":"32","author":"Cherin","year":"2003","journal-title":"Presse Med"},{"key":"10.1016\/j.jbspin.2006.11.013_bib4","first-page":"1374","article-title":"Treatment of orbital myositis with adalimumab (Humira)","volume":"32","author":"Adams","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2006.11.013_bib5","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/rheumatology\/keh539","article-title":"Advanced refractory polymyositis responding to infliximab","volume":"44","author":"Anandacoomarasamy","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2006.11.013_bib6","doi-asserted-by":"crossref","unstructured":"Dold S, Justiniano ME, Marquez J, Espinoza LR. Treatment of early and refractory dermatomyositis with infliximab: a report of two cases. Clin Rheumatol, 2006 May 31; [Epub ahead of print].","DOI":"10.1007\/s10067-006-0325-z"},{"key":"10.1016\/j.jbspin.2006.11.013_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000070852","article-title":"Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: preliminary observations","volume":"50","author":"Hengstman","year":"2003","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jbspin.2006.11.013_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000079547","article-title":"Treatment of dermatomyositis and polymyositis with anti-tumor necrosis factor-alpha: long-term follow-up","volume":"52","author":"Hengstman","year":"2004","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jbspin.2006.11.013_bib9","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/rheumatology\/keh226","article-title":"Successful treatment of alveolar hypoventilation due to dermatomyositis with anti-tumour necrosis factor-alpha","volume":"43","author":"Korkmaz","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2006.11.013_bib10","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/rheumatology\/keh079","article-title":"Refractory polymyositis responding to infliximab: extended follow-up","volume":"43","author":"Labioche","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2006.11.013_bib11","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/rheumatology\/keh700","article-title":"Fatal Mycobacterium peregrinum pneumonia in refractory polymyositis treated with infliximab","volume":"44","author":"Marie","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2006.11.013_bib12","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/rheumatology\/41.10.1194","article-title":"Non-Hodgkin's lymphoma in a patient with refractory dermatomyositis which had been treated with infliximab","volume":"41","author":"Roddy","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2006.11.013_bib13","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/rheumatology\/keh285","article-title":"Refractory adult dermatomyositis with pneumatosis cystoides intestinalis treated with Infliximab","volume":"43","author":"Selva-O'Callaghan","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2006.11.013_bib14","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/rheumatology\/keh062","article-title":"Treatment of myositis with etanercept (enbrel), a recombinant human soluble fusion protein of TNF-alpha type II receptor and IgG1","volume":"43","author":"Sprott","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2006.11.013_bib15","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/rheumatology\/keh268","article-title":"Refractory polymyositis responding to Infliximab","volume":"43","author":"Uthman","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2006.11.013_bib16","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/ard.2005.048744","article-title":"Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients","volume":"65","author":"Efthimiou","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2006.11.013_bib17","first-page":"1802","article-title":"Use of etanercept in the treatment of dermatomyositis: a case series","volume":"33","author":"Iannone","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2006.11.013_bib18","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1093\/rheumatology\/keg388","article-title":"Polymyositis associated with infliximab treatment for rheumatoid arthritis","volume":"42","author":"Musial","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2006.11.013_bib19","first-page":"136","article-title":"Orbital myositis in a rheumatoid arthritis patient during etanercept treatment","volume":"21","author":"Caramaschi","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2006.11.013_bib20","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/art.20849","article-title":"Rituximab in the treatment of dermatomyositis: an open-label pilot study","volume":"52","author":"Levine","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2006.11.013_bib21","first-page":"1021","article-title":"Rituximab as therapy for refractory polymyositis and dermatomyositis","volume":"33","author":"Noss","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2006.11.013_bib22","first-page":"1369","article-title":"Efficacy of rituximab in refractory polymyositis","volume":"32","author":"Lambotte","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2006.11.013_bib23","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/ard.2005.045898","article-title":"Rituximab in the treatment of antisynthetase syndrome","volume":"65","author":"Brulhart","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2006.11.013_bib24","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/01.rhu.0000182155.08982.60","article-title":"Rituximab in the treatment of refractory dermatomyositis","volume":"11","author":"Chiappetta","year":"2005","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2006.11.013_bib25","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1136\/ard.2004.032359","article-title":"Contribution of tumour necrosis factor alpha and interleukin (IL) 1beta to IL6 production, NF-kappaB nuclear translocation, and class I MHC expression in muscle cells: in vitro regulation with specific cytokine inhibitors","volume":"64","author":"Chevrel","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2006.11.013_bib26","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2169\/internalmedicine.39.128","article-title":"Abnormal IL-1 receptor antagonist production in patients with polymyositis and dermatomyositis","volume":"39","author":"Son","year":"2000","journal-title":"Intern Med"},{"key":"10.1016\/j.jbspin.2006.11.013_bib27","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1191\/0961203304lu1047cr","article-title":"IL-1RA in refractory systemic lupus erythematosus","volume":"13","author":"Moosig","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.jbspin.2006.11.013_bib28","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1212\/01.wnl.0000192258.32408.54","article-title":"Pilot trial of etanercept in the treatment of inclusion-body myositis","volume":"66","author":"Barohn","year":"2006","journal-title":"Neurology"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X07001601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X07001601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,28]],"date-time":"2019-04-28T10:25:37Z","timestamp":1556447137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X07001601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S1297319X07001601"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2006.11.013","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}